307 filings
Page 4 of 16
CORRESP
MDWD
MediWound Ltd
22 Nov 22
Correspondence with SEC
12:00am
UPLOAD
MDWD
MediWound Ltd
16 Nov 22
Letter from SEC
12:00am
6-K
MDWD
MediWound Ltd
15 Nov 22
MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update
7:05am
6-K/A
MDWD
MediWound Ltd
14 Nov 22
Current report (foreign) (amended)
4:06pm
F-1
MDWD
MediWound Ltd
10 Nov 22
Registration statement (foreign)
4:13pm
6-K
MDWD
MediWound Ltd
9 Nov 22
Current report (foreign)
4:05pm
6-K
MDWD
MediWound Ltd
21 Oct 22
Current report (foreign)
4:05pm
D
MDWD
MediWound Ltd
6 Oct 22
$17.24 mm in options / securities to be acquired, sold $17.24 mm, 10 investors
4:06pm
D
MDWD
MediWound Ltd
4 Oct 22
$13.26M in equity / options / securities to be acquired, sold $13.26M, 13 investors
6:03am
6-K
MDWD
MediWound Ltd
26 Sep 22
MediWound Announces Concurrent Registered Direct
4:05pm
SC 13D/A
Access Industries Holdings LLC
26 Sep 22
MediWound / Access Industries ownership change
1:42pm
424B5
MDWD
MediWound Ltd
22 Sep 22
Prospectus supplement for primary offering
5:16pm
6-K
MDWD
MediWound Ltd
20 Sep 22
Current report (foreign)
7:05am
6-K
MDWD
MediWound Ltd
9 Aug 22
MediWound Reports Second Quarter 2022 Financial Results and Provides
7:35am
S-8
MDWD
MediWound Ltd
9 Aug 22
Registration of securities for employees
12:00am
6-K
MDWD
MediWound Ltd
8 Aug 22
MediWound Enhances Its Board and Executive Leadership Team
4:10pm
6-K
MDWD
MediWound Ltd
3 Aug 22
MediWound Announces U.S. FDA Acceptance of Biologics License
7:35am
6-K
MDWD
MediWound Ltd
19 Jul 22
Current report (foreign)
4:05pm
6-K
MDWD
MediWound Ltd
12 Jul 22
Current report (foreign)
4:05pm
6-K
MDWD
MediWound Ltd
11 Jul 22
MediWound Announces Positive Initial Data from its U.S. Phase I/II Study of MW005
7:05am